Quick Answer
NUTRA PHARMA CORP reported Cash and Equivalents of $15.5 thousand for fiscal year 2014.
NUTRA PHARMA CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2014 | $15.5K | +234.7% |
| 2013 | $4.6K | -38.6% |
| 2012 | $7.6K | — |
| 2011 | $0.00 | — |
| 2010 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2014 | $27.8K | +9.0% | -36.8% |
| June 30, 2014 | $44.0K | — | +324.4% |
| March 31, 2014 | $10.4K | — | +123.3% |
| December 31, 2013 | $4.6K | -38.6% | -81.8% |
| September 30, 2013 | $25.5K | +179.9% | — |
| June 30, 2013 | $0.00 | — | — |
| March 31, 2013 | $0.00 | — | -100.0% |
| December 31, 2012 | $7.6K | — | -17.1% |
- NUTRA PHARMA CORP showed an increase of +234.7% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from NUTRA PHARMA CORP’s fiscal year 2014 report (Form 10-K), filed with the SEC on April 13, 2015.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: